BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25046419)

  • 1. Ceritinib (Zykadia) for non-small cell lung cancer.
    Med Lett Drugs Ther; 2014 Jul; 56(1447):62-3. PubMed ID: 25046419
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib.
    Toyokawa G; Inamasu E; Shimamatsu S; Yoshida T; Nosaki K; Hirai F; Yamaguchi M; Seto T; Takenoyama M; Ichinose Y
    J Thorac Oncol; 2015 Jul; 10(7):e55-7. PubMed ID: 26134233
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceritinib versus chemotherapy in ALK-positive lung cancer.
    Marshall H
    Lancet Respir Med; 2016 Dec; 4(12):952-953. PubMed ID: 27838332
    [No Abstract]   [Full Text] [Related]  

  • 4. Ceritinib for the treatment of late-stage (metastatic) non-small cell lung cancer.
    Massarelli E; Papadimitrakopoulou V
    Clin Cancer Res; 2015 Feb; 21(4):670-4. PubMed ID: 25564153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-small cell lung cancer: Remarkable developments].
    Vignot S; Wislez M
    Bull Cancer; 2015 Dec; 102(12):962-3. PubMed ID: 26597477
    [No Abstract]   [Full Text] [Related]  

  • 6. Ceritinib gains FDA approval for lung cancer.
    Cancer Discov; 2014 Jul; 4(7):753-4. PubMed ID: 25002599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceritinib Aggravates Glycemic Control in Insulin-treated Patients with Diabetes and Metastatic ALK-positive Lung Cancer.
    Sakuma I; Nagano H; Yoshino I; Yokote K; Tanaka T
    Intern Med; 2019 Mar; 58(6):817-820. PubMed ID: 30449809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDK378 compassionate use for treating carcinomatous meningitis in an ALK translocated non-small-cell lung cancer.
    Arrondeau J; Ammari S; Besse B; Soria JC
    J Thorac Oncol; 2014 Aug; 9(8):e62-3. PubMed ID: 25157781
    [No Abstract]   [Full Text] [Related]  

  • 9. The new drugs and biologics as sensitizers in the treatment of non-small cell lung cancer.
    Turrisi AT
    Suppl Tumori; 2002; 1(4):S55-7. PubMed ID: 12415822
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer drugs. Smart weapons prove tough to design.
    Couzin J
    Science; 2002 Oct; 298(5593):522-5. PubMed ID: 12386312
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyclooxygenase 2 inhibitors and lung carcinoma].
    Spano JP; Chouahnia K; Morère JF
    Bull Cancer; 2004 May; 91 Suppl 2():S109-12. PubMed ID: 15899634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bar the windows but open the door to randomization.
    Ratain MJ
    J Clin Oncol; 2010 Jul; 28(19):3104-6. PubMed ID: 20516430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gefitinib in non-small cell lung cancer].
    Nakagawa K
    Nihon Rinsho; 2004 Jul; 62(7):1312-20. PubMed ID: 15283149
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects, possibilities and limits. Cytostatic therapy of small cell and non-small cell lung cancer].
    Bergman B
    Lakartidningen; 1997 Apr; 94(18):1702, 1707-10. PubMed ID: 9182178
    [No Abstract]   [Full Text] [Related]  

  • 15. Perugia International Cancer Conference I. Chemotherapy of non-small cell lung cancer. June 17-18, 1988, Perugia, Italy. Proceedings.
    Semin Oncol; 1988 Dec; 15(6 Suppl 7):1-70. PubMed ID: 2851169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].
    Kobayashi K
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1747-56. PubMed ID: 8937484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients with advanced non-small-cell lung cancer with performance status of 2: an unsolved issue.
    Gridelli C
    Clin Lung Cancer; 2008 Nov; 9(6):324-5. PubMed ID: 19073513
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Greco FA
    N Engl J Med; 2001 Mar; 344(9):689; author reply 690. PubMed ID: 11229343
    [No Abstract]   [Full Text] [Related]  

  • 19. Lung cancer. Chemotherapy.
    Engelking C
    Am J Nurs; 1987 Nov; 87(11):1438-9, 1440-1. PubMed ID: 2823610
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism of platelet-derived growth factor receptor in non small cell lung cancer: rationale and investigations.
    Bauman JE; Eaton KD; Martins RG
    Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4632-6. PubMed ID: 17671155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.